noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Western Nevada College

Traveling Exhibit Features Six Nevada Artists in Bristlecone Gallery
FASEB - Federation of American[...]

FASEB Submits Comments to OSTP on Accelerating the American Scientific[...]
Klamath County, OR

Klamath County Seeking a Volunteer to serve as an Alternate on the[...]

Healthcare

Praxis Precision Medicines Inc.

01/06/2026 | Press release | Distributed by Public on 01/06/2026 15:24

Business/Financial Results (Form 8-K)

Item 2.02. Results of Operations and Financial Condition.

Praxis Precision Medicines, Inc. (the "Company") is providing the following financial information. As of December 31, 2025, the Company's cash, cash equivalents and marketable securities were approximately $925 million.

The cash, cash equivalents and marketable securities information above is based on preliminary unaudited information and management estimates for the year ended December 31, 2025, is not a comprehensive statement of the Company's financial results as of and for the fiscal year ended December 31, 2025, and is subject to completion of the Company's financial closing procedures. The Company's independent registered public accounting firm has not conducted an audit or review of, and does not express an opinion or any other form of assurance with respect to, this preliminary estimate.

The information contained in this item is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such filing.

Praxis Precision Medicines Inc. published this content on January 06, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on January 06, 2026 at 21:24 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]